{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:28:28Z","timestamp":1789921708043,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T00:00:00Z","timestamp":1363737600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hormonal treatment might affect the immune response to tumor antigens induced in cancer patients who are being vaccinated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 33\u2009years-old woman was diagnosed with cutaneous melanoma in May 2009. Her melanoma was located in the intermammary sulcus, had a Breslow thickness of 4\u2009mm, a Clark\u2019s level IV, it was ulcerated and highly melanotic. The bilateral sentinel node biopsy was negative. She entered into a randomized Phase II\/III clinical study comparing a vaccine composed of irradiated melanoma cells plus BCG plus GM-CSF versus IFN-alpha 2b and she was assigned to the vaccine arm. During the two years treatment she remained disease-free; the final CAT scan being performed in August 2011. Between November and December 2011, her gynecologist treated her with three cycles of 200\u2009mg progesterone\/day for ten days, every two weeks, for ovary dysfunction. In November 2011 the patient returned to the Hospital for clinical and imaging evaluation and no evidence of disease was found. At the next visit in March 2012 an ultrasound revealed multiple, large metastases in the liver. A CAT scan confirmed the presence of liver, adrenal glands and spleen metastases. A needle biopsy of a liver lesion revealed metastatic melanoma of similar characteristics to the original tumor. We suggest that progesterone treatment triggered proliferation of so far dormant micrometastases that were controlled during CSF470 vaccine treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The use of progesterone in patients with melanoma that are under immunological treatments should be carefully considered, since progesterone could modify the balance of pro-inflammatory and Th1 functions to a regulatory and anti-inflammatory profile of the immune system that could have an impact in tumor progression.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2407-13-132","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T07:14:12Z","timestamp":1363763652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment"],"prefix":"10.1186","volume":"13","author":[{"given":"Jose","family":"Mordoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana Jaqueline","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Marcela","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,20]]},"reference":[{"key":"3758_CR1","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/1097-0142(19850315)55:6<1340::AID-CNCR2820550630>3.0.CO;2-T","volume":"55","author":"DS Reintgen","year":"1985","unstructured":"Reintgen DS, McCarty KS, Vollmer R, Cox E, Seigler HF: Malignant melanoma and pregnancy. Cancer. 1985, 55: 1340-1344. 10.1002\/1097-0142(19850315)55:6<1340::AID-CNCR2820550630>3.0.CO;2-T.","journal-title":"Cancer"},{"key":"3758_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/01.cmr.0000232295.91536.09","volume":"16","author":"V Silipo","year":"2006","unstructured":"Silipo V, De Simone P, Mariani G, Buccini P, Ferrari A, Catricala C: Malignant melanoma and pregnancy. Melanoma Res. 2006, 16: 497-500. 10.1097\/01.cmr.0000232295.91536.09.","journal-title":"Melanoma Res"},{"key":"3758_CR3","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.ejca.2011.04.023","volume":"47","author":"S Gandini","year":"2011","unstructured":"Gandini S, Iodice S, Koomen E, Di Pietro A, Sera F, Caini S: Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Eur J Cancer. 2011, 47: 2607-2617. 10.1016\/j.ejca.2011.04.023.","journal-title":"Eur J Cancer"},{"key":"3758_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/01.cji.0000208258.79005.5f","volume":"29","author":"MM Barrio","year":"2006","unstructured":"Barrio MM, de Motta PT, Kaplan J, von Euw EM, Bravo AI, Chac\u00f3n RD, Mordoh J: A phase I study of an allogeneic cell vaccine (VACCIMEL) with GM-CSF in melanoma patients. J Immunother. 2006, 29: 444-454. 10.1097\/01.cji.0000208258.79005.5f.","journal-title":"J Immunother"},{"key":"3758_CR5","first-page":"P05","volume-title":"11th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology DC2010: Forum on Vaccine Science: 26\u201330 September 2010","author":"AM Copati","year":"2010","unstructured":"Copati AM, Pizzurro GA, Pujol-Lereis LM, Quesada-Allu\u00e9 LA, Duzelman VJ, Roberti MP, Levy EM, Teillaud JL, Barrio MM, Mordoh J: Analysis of irradiated melanoma cell lines as antigen source in clinical trials. Update of two Phase I clinical trials and an ongoing Phase II\/III clinical trial in melanoma patients. 11th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology DC2010: Forum on Vaccine Science: 26\u201330 September 2010. 2010, Lugano: IRB-Institute for Research in Biomedicine, P05-P082."},{"key":"3758_CR6","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1200\/JCO.2002.07.044","volume":"20","author":"O Eton","year":"2002","unstructured":"Eton O, Legha SS, Bedikian AY, Lee JJ, Buzaid AC, Hodges C, Ring SE, Papadopoulos NE, Plager C, East MJ, Zhan F, Benjamin RS: Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a Phase III randomized trial. J Clin Oncol. 2002, 20: 2045-2052. 10.1200\/JCO.2002.07.044.","journal-title":"J Clin Oncol"},{"key":"3758_CR7","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.2741\/2817","volume":"13","author":"J Szekeres-Bartho","year":"2008","unstructured":"Szekeres-Bartho J, Wilczynski JR, Basta P, Kalinka J: Role of progesterone and progestin therapy in threatened abortion and preterm labour. Front Biosci. 2008, 13: 1981-1990. 10.2741\/2817.","journal-title":"Front Biosci"},{"key":"3758_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsbmb.2008.11.003","volume":"113","author":"MA De Le\u00f3n-Nava","year":"2009","unstructured":"De Le\u00f3n-Nava MA, Nava K, Soldevila G, L\u00f3pez-Griego L, Ch\u00e1vez-R\u00edos JR, Vargas-Villavicencio JA, Morales-Montor J: Immune sexual dimorphism: effect of gonadal steroids on the expression of cytokines, sex steroid receptors, and lymphocyte proliferation. J Steroid Biochem Mol Biol. 2009, 113: 57-64. 10.1016\/j.jsbmb.2008.11.003.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3758_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4049\/jimmunol.155.1.128","volume":"155","author":"MP Piccinni","year":"1995","unstructured":"Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C: Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol. 1995, 155: 128-133.","journal-title":"J Immunol"},{"key":"3758_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1034\/j.1600-0897.2002.01141.x","volume":"48","author":"A Canellada","year":"2002","unstructured":"Canellada A, Blois S, Gentile T, Margni Idehu RA: In vitro modulation of protective antibody responses by estrogen, progesterone and interleukin-6. Am J Reprod Immunol. 2002, 48: 334-343. 10.1034\/j.1600-0897.2002.01141.x.","journal-title":"Am J Reprod Immunol"},{"key":"3758_CR11","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1210\/jc.2003-031647","volume":"89","author":"C Dosiou","year":"2004","unstructured":"Dosiou C, Lathi RB, Tulac S, Huang ST, Giudice LC: Interferon-related and other immune genes are downregulated in peripheral blood leukocytes in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab. 2004, 89: 2501-2504.","journal-title":"J Clin Endocrinol Metab"},{"key":"3758_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2217\/imt.09.54","volume":"1","author":"J Szekeres-Bartho","year":"2009","unstructured":"Szekeres-Bartho J: Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage. Immunotherapy. 2009, 1: 873-882. 10.2217\/imt.09.54.","journal-title":"Immunotherapy"},{"key":"3758_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.yhbeh.2012.02.023","volume":"62","author":"DP Robinson","year":"2012","unstructured":"Robinson DP, Klein SL: Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 2012, 62: 263-271. 10.1016\/j.yhbeh.2012.02.023.","journal-title":"Horm Behav"},{"key":"3758_CR14","doi-asserted-by":"publisher","first-page":"9845","DOI":"10.1128\/JVI.77.18.9845-9851.2003","volume":"77","author":"AE Gillgrass","year":"2003","unstructured":"Gillgrass AE, Ashkar AA, Rosenthal KL, Kaushic C: Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J Virol. 2003, 77: 9845-9851. 10.1128\/JVI.77.18.9845-9851.2003.","journal-title":"J Virol"},{"key":"3758_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/QAI.0b013e3180471bae","volume":"45","author":"LM Enomoto","year":"2007","unstructured":"Enomoto LM, Kloberdanz KJ, Mack DG, Elizabeth D, Weinberg AJ: Ex vivo effect of estrogen and progesterone compared with dexamethasone on cell-mediated immunity of HIV-infected and uninfected subjects. J Acquir Immune Defic Syndr. 2007, 45: 137-143. 10.1097\/QAI.0b013e3180471bae.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3758_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00002030-200401230-00009","volume":"18","author":"CC Wang","year":"2004","unstructured":"Wang CC, McClelland RS, Overbaugh J, Reilly M, Panteleeff DD, Mandaliya K, Chohan B, Lavreys L, Ndinya-Achola J, Kreiss JK: The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS. 2004, 18: 205-209. 10.1097\/00002030-200401230-00009. Metab. 2004 May;89(5):2501\u20134.","journal-title":"AIDS"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-132\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T11:16:56Z","timestamp":1688123816000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,20]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3758"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-132","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,20]]},"assertion":[{"value":"20 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"132"}}